$FIG

Mulligan Brendan sold $455K of FIG

Mulligan Brendan (General Counsel and Secretary) sold 18,213 shares of Figma, Inc. (FIG) at $25.00 ($0.46M total) on 2026-07-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Mulligan Brendan
Published Jul 31, 2026, 11:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 11:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FIG
Neutral
medium confidence
Mentioned
$FIG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FIGNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details by the company’s General Counsel and Secretary, including trade size, price, and 10b5-1 status.

02

Market read

Insider selling can influence short-term sentiment, but 10b5-1 plans typically reduce interpretive value.

03

What to watch

Traders may over-weight insider sales; without accompanying buy/sell patterns or changes in executive compensation, the signal is usually weak.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-31, sale dated 2026-07-29

Background

The article is an SEC Form 4 insider transaction disclosure for Figma, Inc.

Company-level read

Ticker impact

$FIGNeutralMedium confidence
Context

Figma Form 4 shows General Counsel Brendan Mulligan sold 18,213 shares at $25.0033 on 2026-07-29 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted given the stated 10b5-1 pre-arranged plan.

Evidence & confidence

The filing is a primary-source Form 4 and includes trade size, price, and 10b5-1 status, but it does not provide new company performance, guidance, or regulatory developments.

Market effects

Minimal, as this is company-specific insider transaction data without sector-wide signal.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity or diversification needs rather than bearish expectations.

Key entities

  • Figma, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Brendan Mulligan

    General Counsel and Secretary who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FIGMedAI 8/10

Why Figma Stock Climbed 13% in August

Figma (FIG) reported Q2 revenue of $370.1M, beating estimates, with 48% YoY growth and raised full-year guidance. Despite strong results, shares fell post-earnings due to high spending but later recovered, ending August up 13%. Investors remain concerned about margins amid AI investments.

$FIGHighAI 9/10

Figma Q2FY26 Results: Revenue up 48% YoY to $370.1 million

Figma Inc (FIG) reported Q2FY26 revenue of $370.1M, up 48% YoY, and raised full-year guidance by $40M. Despite beating estimates, shares dropped 17.51% to $23.22, reflecting valuation concerns. Salesforce's strong earnings lifted peer stocks, highlighting AI as a growth catalyst. Figma's CEO emphasized AI's role in expanding its market.

$PATHMedAI 8/10

Analysts Have a Wall of Holds on Figma, UiPath and GitLab but Institutions Are Quietly Loading Up

Analysts have issued 41 Holds across 61 ratings for UiPath, GitLab, and Figma, with consensus targets below current prices for two. Institutions hold 65% to 95% of the float, building positions despite cautious analyst sentiment. UiPath and GitLab have surged 58% and 36% in one month, respectively, exceeding analyst targets. Figma's target aligns with its current price. All three companies reported strong revenue growth in recent quarters.

$FIGMedAI 8/10

Figma Stock Price Prediction: Wall Street’s $30 Target May Be Too Low

Figma (FIG) is down 61% despite 48% revenue growth, with Wall Street's consensus target at $30.80. Analysts argue for a $40 target, citing faster growth than Adobe (ADBE) and Atlassian (TEAM) and strong AI monetization. Q2 revenue was $370M, with a net dollar retention rate of 136%. Bulls see potential for $50+ if AI adoption continues, while risks include competitive pressure and high valuation multiples.